A common diabetes drug may mimic one key effect of exercise in prostate cancer patients. Researchers found metformin boosts an “exercise molecule” linked to appetite and weight control, even in those ...

Researchers say metformin may mimic some benefits of exercise in prostate cancer patients, helping improve metabolism and manage treatment-related side effects.

A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects ...

Prostate cancer patients treated with the widely prescribed diabetes drug metformin showed elevated blood levels of N-lactoyl ...

A COMMON drug already given to millions of Brits could mimic the effects of “intense” exercise in people who can’t work out, ...

A common diabetes medication could help men with prostate cancer who develop hormone therapy-related metabolic syndrome ...

Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment ...

February 1, 2012 — A new study suggests that vigorous physical activity will offer protection against prostate cancer progression because of its effects on DNA repair and cell-cycle pathways. The ...

Diabetes drug metformin may mimic exercise effects in prostate cancer, supporting weight, metabolism and overall health ...

Among patients receiving metformin, Lac-Phe levels rose and remained elevated even after hormone therapy began. However, the ...